{"nct_id":"NCT04629508","title":"To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2021-07-12","start_date_type":"ACTUAL","primary_completion_date":"2023-08-24","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}